Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots

by admin | Jan 15, 2026 | Uncategorized

Penumbra’s stock was up about 12% after the deal was announced Thursday morning.

← Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots Another Nuclear Play Leans Into Grid Consolidation With $3.45 Billion Natural Gas Deal →

Written By

Written by Albert Pham, News Curator and Blogger

Germany Spy Scandal: BND Intelligence Crisis Threatens European Security

Oct 9, 2026 | albertpham, Politics, Technology, Uncategorized

Germany’s intelligence agency faces a major espionage scandal involving former chief August Hanning, raising concerns over national security, allied trust and intelligence reform.

Trump’s July Financial Disclosure Reveals Major Microsoft and Amazon Stock Trades

Sep 22, 2026 | albertpham, Economy_finances, Politics, Uncategorized

Trump’s July financial disclosure shows 1,156 securities transactions, including major Microsoft and Amazon stock sales worth up to $25 million each.

Stocks tread water — but a wave of volatility is building

May 21, 2026 | Economy_finances, Uncategorized

S&P 500 analysis shows technical sell signals are flashing despite Nvidia earnings hype.

Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots

Written By

Related Posts

Germany Spy Scandal: BND Intelligence Crisis Threatens European Security

Trump’s July Financial Disclosure Reveals Major Microsoft and Amazon Stock Trades

Stocks tread water — but a wave of volatility is building

0 Comments